Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Meiji

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Meiji's Japan sales performance.

Democrats’ final pricing plan announced, 250 drugs targeted

Democrats’ final pricing plan announced, 250 drugs targeted Australia, Canada, France, Germany, Japan and the UK.

Democrats reveal pricing plan with 250-drug hit list

Democrats reveal pricing plan with 250-drug hit list Germany, Japan and the UK.

ALK-Abello debuts its birch pollen allergy therapy in Germany

ALK-Abello debuts its birch pollen allergy therapy in Germany GlobalData said recently that the overall market for allergic rhinitis immunotherapies will reach $1.14bn by 2028, with the US and Japan contributing the lion’s share of growth based on

Medimmune-born Viela files $150m IPO, eyes first product launch

Medimmune-born Viela files $150m IPO, eyes first product launch Meanwhile, Japan’s Chugai also has positive phase 3 data with its NMOSD candidate satralizumab, an interleukin-6 inhibitor partnered with Roche.

Roche’s flu drug Xofluza scores phase 3 primary endpoint

Roche’s flu drug Xofluza scores phase 3 primary endpoint The drug was discovered and developed by Shionogi, and is already approved in Japan, with Roche holding the marketing rights outside Japan and Taiwan.

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics